Biogen Inc (NASDAQ:BIIB)

269.45
Delayed Data
As of Apr 25
 +7.30 / +2.78%
Today’s Change
244.28
Today|||52-Week Range
370.57
-15.42%
Year-to-Date
Biotech Stock Roundup: PRTA Down, AMGN Revises View, BIIB Misses on Sales
Apr 25 / Zacks.com - Paid Partner Content
Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus
Apr 23 / Zacks.com - Paid Partner Content
Wall Street Mixed Wednesday
Apr 25 / GuruFocus News - Paid Partner Content
Novartis (NVS) Reports Encouraging Data on MS Candidate
Apr 20 / Zacks.com - Paid Partner Content
Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX
Apr 25 / Zacks.com - Paid Partner Content
What's in Store for Biogen (BIIB) This Earnings Season?
Apr 20 / Zacks.com - Paid Partner Content
Biogen (BIIB) Q1 Earnings Beat, Sales Miss, Shares Down
Apr 24 / Zacks.com - Paid Partner Content
Broadleaf Partners, LLC Buys NVIDIA Corp, Sherwin-Williams Co, Schwab International E...
Apr 20 / GuruFocus News - Paid Partner Content
Biogen (BIIB) Q1 Earnings Beat, Sales Miss
Apr 24 / Zacks.com - Paid Partner Content
Mylan Fujifilm Kyowa Team Up to Market Humira Biosimilar
Apr 12 / Zacks.com - Paid Partner Content
Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN
Apr 23 / Zacks.com - Paid Partner Content